Research is the backbone of Brainwave Optimisation. The intensive ongoing research both verifies and expands the efficacy and the range of interventions we can offer. Rigorous, significant research demands a great deal of time and resources, but it is essential to our work at Balance Your Brain.

Much of the research into Brainwave Optimisation has been conducted by a number of independent, third-party researchers are investigating our process and methodology.

In particular, a team of neuroscientists from Wake Forest School of Medicine, under the direction of lead investigator Charles H Tegeler, MD (McKinney-Avant Professor of Neurology, Director of Telestroke Services, and Director of the Ward A. Riley Ultrasound Center), are testing the efficacy of Brainwave Optimisation as an intervention for a variety of conditions. Two of their studies have already seen publication and in 2013 they were awarded a $1 million grant to continue and expand their research. To date they have been awarded more than $1.7 million in outside funding to facilitate research related to Brainwave Optimisation.

As of this writing, the HIRREM Research Program at Wake Forest School of Medicine, led by Dr. Charles Tegeler, has since 2012 produced a cumulative total of 18 peer-reviewed scientific publications (two full-length manuscripts, fifteen abstracts presented at eleven different scientific conferences, and a letter to the editor of JAMA Psychiatry). Dr. Tegeler’s program is now in its third year of independent funding, to show that the brain itself, when self-optimized, can generate benefits beyond what can be done with medical intervention. Not included in the above is the latest paper, now under review, reporting on use of HIRREM (BWO) for a case series of adolescents with postural tachycardia syndrome (POTS). POTS can be a debilitating disorder of autonomic dysregulation, and a number of individuals with this condition have reported significant improvements after using BWO. POTS work is significant as it should be national news. Though there are only about 200,000 diagnosed cases of POTS in the U.S., there is no real highly efficacious option for them. The lead author of the paper is Dr. John Fortunato of the University of Colorado at Denver, who is a pediatric neuro-gastroenterologist and a colleague of Dr. Tegeler.